Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorders: A Brief Guide
Guidelines or Manual -ELECTRONIC ONLY
Download Digital Version
Offers guidance on the use of medication-assisted treatment (MAT) with extended-release injectable naltrexone for the treatment of an opioid use disorder. Covers patient assessment, initiating MAT, monitoring progress, and deciding when to end treatment.
Pub id: SMA14-4892
Publication Date: 12/2014
Last Reviewed: 01/05/2015
Popularity: Not ranked
Format: Guidelines or Manual
Audience: Professional Care Providers
Population Group: Patients
.-.-.-.
Patient and Family-friendly links from NIH
You May Also Be Interested In
TAP 30: Buprenorphine: A Guide for NursesGives nurses information about buprenorphine for medication-assisted treatment...
Managing Chronic Pain in Adults With or in Recovery From Substance Use DisordersProvides clinicians with a quick reference guide for treating chronic pain in...
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment ProgramsOffers clinicians guidelines on using medication-assisted treatment in opioid...
TIP 49: Incorporating Alcohol Pharmacotherapies Into Medical PracticeProvides clinical practice guidelines for using four medications in the...
TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment ProgramsGives a detailed description of medication-assisted treatment for addiction to...
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid AddictionOffers guidelines to physicians using buprenorphine for the medication-assisted...
.-.-.-.
.png)
No hay comentarios:
Publicar un comentario